tetano
Editor, Senior Moderator
Crit Care
. 2020 Sep 16;24(1):559.
doi: 10.1186/s13054-020-03273-y.
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations
Adam Flaczyk[SUP] 1 [/SUP], Rachel P Rosovsky[SUP] 2 [/SUP], Clay T Reed[SUP] 3 [/SUP], Brittany K Bankhead-Kendall[SUP] 4 [/SUP], Edward A Bittner[SUP] 1 [/SUP], Marvin G Chang[SUP] 5 [/SUP]
Affiliations
Abstract
Critically ill patients with COVID-19 are at increased risk for thrombotic complications which has led to an intense debate surrounding their anticoagulation management. In the absence of data from randomized controlled clinical trials, a number of consensus guidelines and recommendations have been published to facilitate clinical decision-making on this issue. However, substantive differences exist between these guidelines which can be difficult for clinicians. This review briefly summarizes the major societal guidelines and compares their similarities and differences. A common theme in all of the recommendations is to take an individualized approach to patient management and a call for prospective randomized clinical trials to address important anticoagulation issues in this population.
Keywords: Anticoagulation; COVID-19; Coronavirus; Hematologic monitoring; Therapeutic anticoagulation; Thrombosis; Venous thromboembolism.
. 2020 Sep 16;24(1):559.
doi: 10.1186/s13054-020-03273-y.
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations
Adam Flaczyk[SUP] 1 [/SUP], Rachel P Rosovsky[SUP] 2 [/SUP], Clay T Reed[SUP] 3 [/SUP], Brittany K Bankhead-Kendall[SUP] 4 [/SUP], Edward A Bittner[SUP] 1 [/SUP], Marvin G Chang[SUP] 5 [/SUP]
Affiliations
- PMID: 32938471
- DOI: 10.1186/s13054-020-03273-y
Abstract
Critically ill patients with COVID-19 are at increased risk for thrombotic complications which has led to an intense debate surrounding their anticoagulation management. In the absence of data from randomized controlled clinical trials, a number of consensus guidelines and recommendations have been published to facilitate clinical decision-making on this issue. However, substantive differences exist between these guidelines which can be difficult for clinicians. This review briefly summarizes the major societal guidelines and compares their similarities and differences. A common theme in all of the recommendations is to take an individualized approach to patient management and a call for prospective randomized clinical trials to address important anticoagulation issues in this population.
Keywords: Anticoagulation; COVID-19; Coronavirus; Hematologic monitoring; Therapeutic anticoagulation; Thrombosis; Venous thromboembolism.